4. Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, et al. 2012; Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 22:21–30. DOI:
10.3109/s10165-011-0571-z. PMID:
22218969.
Article
5. Wallace ZS, Mattoo H, Carruthers M, Mahajan VS, Della Torre E, Lee H, et al. 2015; Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations. Ann Rheum Dis. 74:190–5. DOI:
10.1136/annrheumdis-2014-205233. PMID:
24817416. PMCID:
PMC4656194.
Article
6. Mattoo H, Mahajan VS, Della-Torre E, Sekigami Y, Carruthers M, Wallace ZS, et al. 2014; De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease. J Allergy Clin Immunol. 134:679–87. DOI:
10.1016/j.jaci.2014.03.034. PMID:
24815737. PMCID:
PMC4149918.
Article
8. van den Elshout-den Uyl D, Spoto CPE, de Boer M, Leiner T, Leavis HL, Leguit RJ. 2019; First report of IgG4 related disease primary presenting as vertebral bone marrow lesions. Front Immunol. 10:1910. DOI:
10.3389/fimmu.2019.01910. PMID:
31456806. PMCID:
PMC6700296.
Article